Cumulative Effect of Risk Alleles in CFH, ARMS2, and VEGFA on the Response to Ranibizumab Treatment in Age-related Macular Degeneration-Reference-Cited by-同舟云学术

Cumulative Effect of Risk Alleles in CFH, ARMS2, and VEGFA on the Response to Ranibizumab Treatment in Age-related Macular Degeneration

Published:2012-11 Issue:11 Volume:119 Page:2304-2311
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Smailhodzic Dzenita,Muether Philipp S.,Chen John,Kwestro Angela,Zhang Alice Yang,Omar Amer,Van de Ven Johannes P.H.,Keunen Jan E.E.,Kirchhof Bernd,Hoyng Carel B.,Klevering B. Jeroen,Koenekoop Robert K.,Fauser Sascha,den Hollander Anneke I.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference37 articles.

1. Prevalence of age-related macular degeneration in the United States;Arch Ophthalmol,2004

2. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study;Klein;Ophthalmology,2002

3. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study;Mitchell;Ophthalmology,1995

4. The biology of VEGF and its receptors;Ferrara;Nat Med,2003

5. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes;Frank;Am J Ophthalmol,1996

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neural (Sensory) Retina;Ocular Pathology;2025

2. Association of the Complement Factor H Y402H Polymorphism and Response to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration: An Updated Meta-Analysis;Ophthalmic Research;2024-05-21

3. Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study;Clinical & Experimental Ophthalmology;2024-05-16

4. CCR1 mediates Müller cell activation and photoreceptor cell death in macular and retinal degeneration;eLife;2023-10-30

5. Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration;Investigative Opthalmology & Visual Science;2023-10-20